(Q41739650)

8 October 2017

1 reference

title

New visions in the pharmacology of anticonvulsion (English)

1 reference

8 October 2017

1 reference

Löscher W

1

1 reference

8 October 2017

language of work or name

English

0 references

publication date

1 January 1998

1 reference

European Journal of Pharmacology

8 October 2017

number of pages

13

1 reference

based on heuristic

inferred from page(s)

published in

1 reference

8 October 2017

volume

342

1 reference

8 October 2017

issue

1

1 reference

8 October 2017

page(s)

1-13

1 reference

Shaking down new epilepsy genes

8 October 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901514-8

Progress report on new antiepileptic drugs: a summary of the Third Eilat Conference

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901514-8

Lamotrigine substitution study: evidence for synergism with sodium valproate? 105 Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901514-8

An overview of the efficacy and tolerability of new antiepileptic drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901514-8

Proposal for revised clinical and electroencephalographic classification of epileptic seizures. From the Commission on Classification and Terminology of the International League Against Epilepsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901514-8

Proposal for revised classification of epilepsies and epileptic syndromes. Commission on Classification and Terminology of the International League Against Epilepsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901514-8

Benzodiazepines on trial: a research strategy for their rehabilitation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901514-8

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901514-8

Emerging insights into mechanisms of epilepsy: implications for new antiepileptic drug development

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901514-8

Excitatory amino acid receptors in epilepsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901514-8

New targets for drug action: is high selectivity always beneficial?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901514-8

Vigabatrin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in epilepsy and disorders of motor control

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901514-8

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901514-8

Strategies for the development of drugs for pharmacoresistant epilepsies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901514-8

Utility of the lethargic (lh/lh) mouse model of absence seizures in predicting the effects of lamotrigine, vigabatrin, tiagabine, gabapentin, and topiramate against human absence seizures

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901514-8

The convulsant and anticonvulsant effects of phencyclidine (PCP) and PCP analogues in the rat.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901514-8

Valproate enhances GABA turnover in the substantia nigra

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901514-8

Animal models of intractable epilepsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901514-8

High doses of memantine (1-amino-3,5-dimethyladamantane) induce seizures in kindled but not in non-kindled rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901514-8

Responses to NMDA receptor antagonists altered by epileptogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901514-8

Increase of human plasma GABA by sodium valproate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901514-8

Which animal models should be used in the search for new antiepileptic drugs? A proposal based on experimental and clinical considerations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901514-8

Strategies in antiepileptic drug development: is rational drug design superior to random screening and structural variation?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901514-8

Gabapentin increases aminooxyacetic acid-induced GABA accumulation in several regions of rat brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901514-8

Plasma GABA and seizure control with vigabatrin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901514-8

Low doses of NMDA receptor antagonists synergistically increase the anticonvulsant effect of the AMPA receptor antagonist NBQX in the kindling model of epilepsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901514-8

Kindling as a model of drug-resistant partial epilepsy: selection of phenytoin-resistant and nonresistant rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901514-8

Determination of GABA and vigabatrin in human plasma by a rapid and simple HPLC method: correlation between clinical response to vigabatrin and increase in plasma GABA

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901514-8

Seizure suppression in kindling epilepsy by grafts of fetal GABAergic neurons in rat substantia nigra

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901514-8

Antiepileptic drug actions.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901514-8

Antiepileptic drug mechanisms of action

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901514-8

Cellular and molecular basis of epilepsy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901514-8

7 January 2021

GABA and epileptogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901514-8

The new generation of antiepileptic drugs: advantages and disadvantages

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901514-8

Human brain GABA levels rise rapidly after initiation of vigabatrin therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901514-8

The effect of gabapentin on brain gamma-aminobutyric acid in patients with epilepsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901514-8

Adverse effects of established and new antiepileptic drugs: an attempted comparison

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901514-8

Drug treatment of epilepsy in the 1990s. Achievements and new developments.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901514-8

The evaluation and treatment of seizures

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901514-8

The new anticonvulsant drugs. Implications for avoidance of adverse effects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901514-8

Does antiepileptic drug therapy prevent the development of "chronic" epilepsy?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901514-8

A review of evidence for GABergic predominance/glutamatergic deficit as a common etiological factor in both schizophrenia and affective psychoses: More support for a continuum hypothesis of ?functional? psychosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901514-8

3-Alkyl GABA and 3-alkylglutamic acid analogues: two new classes of anticonvulsant agents

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901514-8

Vigabatrin and behaviour disorders: a retrospective survey.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901514-8

Mechanisms of action of new antiepileptic drugs: rational design and serendipitous findings

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901514-8

Effect of carbamazepine, oxcarbazepine and lamotrigine on the increase in extracellular glutamate elicited by veratridine in rat cortex and striatum

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901514-8

Clinical significance of animal seizure models and mechanism of action studies of potential antiepileptic drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901514-8

Low doses of the glycine/NMDA receptor antagonist R-(+)-HA-966 but not D-cycloserine induce paroxysmal activity in limbic brain regions of kindled rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901514-8

Experimental animal models of epilepsy: classification and relevance to human epileptic phenomena

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901514-8

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0014-2999(97)01514-8

1 reference

release_5gmmprtkmfgddhwin5gaseh5wq

8 October 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/5gmmprtkmfgddhwin5gaseh5wq

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference